RESEARCH-USE BIOSIMILAR ANTIBODY
Zamerovimab
Monoclonal antibody · IgG1
Zamerovimab (CTB011) is an anti-rabies humanized IgG1κ monoclonal antibody that binds to the non-overlapping epitopes on the rabies virus (RABV) glycoprotein. Zamerovimab targets residues at and near antigenic site III. Zamerovimab can be used in rabies studies.
TARGETRabies Virus Spike Glycoprotein G
YMonoclonal antibody
CATALOGSC-BS-024
CATALOG NUMBERSC-BS-024
MOLECULAR WEIGHTApprox. 145.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Zamerovimab (CTB011) is an anti-rabies humanized IgG1κ monoclonal antibody that binds to the non-overlapping epitopes on the rabies virus (RABV) glycoprotein. Zamerovimab targets residues at and near antigenic site III. Zamerovimab can be used in rabies studies.
Zamerovimab is a recombinant research-use antibody directed against Rabies Virus Spike Glycoprotein G.